122 related articles for article (PubMed ID: 2055424)
1. Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
Lizasoain I; Leza JC; Lorenzo P
Gen Pharmacol; 1991; 22(2):297-300. PubMed ID: 2055424
[TBL] [Abstract][Full Text] [Related]
2. Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
Fukase H; Fukuzaki K; Koja T; Nagata R; Lukas SE
Psychopharmacology (Berl); 1994 Dec; 116(4):396-400. PubMed ID: 7701039
[TBL] [Abstract][Full Text] [Related]
3. Influence of different benzodiazepines on the experimental morphine abstinence syndrome.
Maldonado R; Micó JA; Valverde O; Saavedra MC; Leonsegui I; Gibert-Rahola J
Psychopharmacology (Berl); 1991; 105(2):197-203. PubMed ID: 1686654
[TBL] [Abstract][Full Text] [Related]
4. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
Fdez Espejo E; Cador M; Stinus L
Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
[TBL] [Abstract][Full Text] [Related]
5. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
Dzoljic MR; Rademaker B; vd Poel-Heisterkamp AL; Ukponmwan OE; Haffmans J
Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):222-8. PubMed ID: 3539055
[TBL] [Abstract][Full Text] [Related]
6. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
7. Effects of antihistaminics on naloxone-induced withdrawal in morphine-dependent mice.
Leza JC; Lizasoain I; Lorenzo P
Psychopharmacology (Berl); 1990; 102(1):106-11. PubMed ID: 1975446
[TBL] [Abstract][Full Text] [Related]
8. The effects of buprenorphine on fentanyl withdrawal in rats.
Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS
Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
[TBL] [Abstract][Full Text] [Related]
10. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
[TBL] [Abstract][Full Text] [Related]
12. Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine.
Sarton E; Teppema L; Dahan A
Adv Exp Med Biol; 2008; 605():486-91. PubMed ID: 18085322
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
[TBL] [Abstract][Full Text] [Related]
14. The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
el Kadi AO; Sharif SI
Pharmacol Biochem Behav; 1996 Sep; 55(1):49-54. PubMed ID: 8870037
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
16. Orphanin FQ/nociceptin inhibits morphine withdrawal.
Kotlińska J; Suder P; Legowska A; Rolka K; Silberring J
Life Sci; 2000 Jan; 66(8):PL119-23. PubMed ID: 10680585
[TBL] [Abstract][Full Text] [Related]
17. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs.
Higgins GA; Sellers EM
Pharmacol Biochem Behav; 1994 May; 48(1):1-8. PubMed ID: 8029278
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
[TBL] [Abstract][Full Text] [Related]
19. The physical dependence liability of butorphanol: a comparative study with morphine.
Horan P; Ho IK
Eur J Pharmacol; 1991 Oct; 203(3):387-91. PubMed ID: 1773823
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine blocks withdrawal in morphine-dependent rat pups.
Stoller DC; Smith FL
Paediatr Anaesth; 2004 Aug; 14(8):642-9. PubMed ID: 15283822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
